Dear NMUsers community,
Does anyone here have any experience with the MIDD pilot program recently
launched by the FDA?
https://www.fda.gov/drugs/development-resources/model-informed-drug-development-pilot-program
Would greatly appreciate an informal chat about the kind of issues put forward
A new position has come up in our Clinical Pharmacology Modelling and
Simulation Group (CPMS) at our Greater London site. This is an excellent role
to use quantitative clinical pharmacology to accelerate the delivery of new
medicines to patients, by enhancing drug development efficiency and
Chao Chen would like to recall the message, "Clinical Pharmacology Modelling &
Simulation Role at GlaxoSmithKline".
GSK monitors email communications sent to and from GSK in order to protect GSK,
our employees, customers, suppliers and business partners, from cyber threats
and loss of GSK
A new position has come up in our Clinical Pharmacology Modelling and
Simulation Group (CPMS) at our Greater London site. This is an excellent role
to use quantitative clinical pharmacology to accelerate the delivery of new
medicines to patients, by enhancing drug development efficiency and
